カルシヌーリンは,圧力の過負荷によって引き起こされる心筋縮に重要な役割を果たします
M Shimoyama1, D Hayashi, E Takimoto
1Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, and the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Circulation
|December 14, 1999
まとめ
カルシヌーリンの活性化は,圧力過負荷への反応として心筋高縮を誘発する. FK506でカルシヌーリンを阻害すると,この高縮が予防され,心臓の適応におけるこの信号伝達経路の重要な役割が示唆されます.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- 心筋縮は,血液動力学的な過負荷に対する適応反応である.
- 機械的な負荷が心筋縮を誘発する正確なメカニズムは,完全に理解されていません.
- 最近の発見によると,カルシネウリンは,カルシウムに依存するフォスファタゼであり,心臓の縮を媒介していることを示唆しています.
研究 の 目的:
- 圧力過負荷によって引き起こされる心筋縮におけるカルシヌーリンの役割を調査する.
- カルシヌーリンの活性化が心筋縮の発達における重要な要因であるかどうかを判断する.
主な方法:
- ネズミでは,腹部大動脈収縮経由で圧力過負荷を誘発する.
- 心臓組織におけるカルシーヌーリンの活性を測定する.
- カルシヌーリンの阻害剤であるFK506を投与し,その効果を評価する.
- 心臓増強症,線維症,遺伝子発現の変化を評価する.
主要な成果:
- 圧力過負荷はカルシーヌーリンの活性を増大させ,心筋縮と遺伝子再プログラムを引き起こした.
- FK506治療はカルシヌーリンの活性化を阻害し,心筋縮と線維症を予防しました.
- FK506は血液動力学的パラメータを変化させなかった.
- 負荷誘発による即時早期応答と胎児遺伝子の発現はFK506.6によって抑制された.
結論:
- カルシーヌーリンのシグナル伝達経路は,負荷誘発性心筋縮において重要な役割を果たします.
- カルシーヌーリンのターゲティングは,心筋縮の予防のための新しい薬理学的戦略を提供することができます.
関連する概念動画
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...